New research at the University of Toronto, found that a two month protocol of probiotics not only boosted chronic fatigue syndrome (CFS) patients “good” bacteria in the gut but also led to a significant decrease in their depression and anxiety symptoms.
It has long been known that probiotics, “Good bacteria” taken in pill or powder form, help maintain healthy gut flora beneficial to general health. Countless studies have shown them to perform a wide variety of healthy functions, including improved digestion, regularity, and improved immune system functioning. But, this new study, published in the journal BMC Gut Pathogens breaks new ground, specifically their effect on the feel-good neurotransmitter L-tryptophan. “We were quite excited with the fact that these were positive results and we felt that probiotics truly have a role to play in the management of neurophysiological disorders such as anxiety, such as depression and other symptoms associated with that,” said Rao, the research leader. “Rather than going into medications, which may result in side effects, it’s a safe, it’s a very easy way to manage problems such as that.”
The study, led by A. Venket Rao and co-authored by Dr. Alison C. Bested, administered 39 CFS patients either three doses of Lactobacillus casei Shirota a day, or a placebo, for two months. They found that 73 per cent of subjects taking the probiotic experienced an increase in levels of Lactobacillus and Bifidobacteria in the gut, which corresponded with a significant decrease in anxiety symptoms. In the placebo group, only 37.5 per cent showed an increase in Bifidobacteria, while only 43.8 per cent showed an increase in Lactobacillus bacteria. The researchers found no statistically significant change in anxiety symptoms among this group.
Rao and Bested believe that probiotics “crowd out” the more toxic stomach bacteria linked to depression and other mood disorders. “Bifidobacteria appears to increase levels of tryptophan in the brain, a chemical that “helps people feel better.” Patients taking the probiotic also showed a marked improvement in their digestion, experiencing less bloating and gas and a reduction in inflammation. The findings are “huge,” Bested said. “The subjects felt less anxious, they felt calmer, they felt better able to cope with their illness, they were sleeping better, had fewer heart palpitations and less symptoms of anxiety,” she said. “We were pleasantly surprised, that people who were taking probiotics were able to lower their anxiety.”
Rao explained that the good bacteria produce “compounds that get to the brain and help the brain to manage problems associated with behavioural and mood problems, such as anxiety and depression.” He said the findings open “a door to a whole new field, and that is the relationship of gut micro flora, or gut bacteria, to many disorders – mental disorders being one of them. So it opens a door to many future research and applications in this area.”